Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study
暂无分享,去创建一个
Sebastian Schneeweiss | Jerry Avorn | Martin Göttler | Joerg Hasford | Annemarie Hoffmann | J. Avorn | S. Schneeweiss | J. Hasford | Ann-Kathrin Riethling | M. Göttler | A. Hoffmann | A. Riethling
[1] S. Schneeweiss,et al. First results from an intensified monitoring system to estimate drug related hospital admissions. , 2001, British journal of clinical pharmacology.
[2] M. Hippius,et al. Adverse drug reaction monitoring--digitoxin overdosage in the elderly. , 2001, International journal of clinical pharmacology and therapeutics.
[3] F. Haramburu,et al. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study , 2000, BMJ : British Medical Journal.
[4] L. Naldi,et al. Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study , 1999, The Lancet.
[5] Jason Lazarou,et al. Incidence of Adverse Drug Reactions in Hospitalized Patients , 1999 .
[6] R. Stern,et al. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. , 1999, Lancet.
[7] E. Roughead,et al. Drug‐related hospital admissions: a review of Australian studies published 1988‐1996 , 1998, The Medical journal of Australia.
[8] M Maclure,et al. Case–crossover and case–time–control designs as alternatives in pharmacoepidemiologic research , 1997, Pharmacoepidemiology and drug safety.
[9] J Hasford,et al. Adverse drug reaction monitoring—cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission , 1997, Pharmacoepidemiology and drug safety.
[10] D. Classen,et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. , 1997, JAMA.
[11] J. Avorn. Putting adverse drug events into perspective. , 1997, JAMA.
[12] J. Hallas,et al. Drug related admissions to medical wards: a population based survey. , 1992, British journal of clinical pharmacology.
[13] R. Royer,et al. ADVERSE DRUG REACTION MONITORING: DOING IT THE FRENCH WAY , 1985, The Lancet.